This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


GE Healthcare


Meet GE Healthcare at BioProcess International on stand number 618

September 9-12 2019, Boston Convention and Exhibition Center, Boston, MA.

GE Healthcare are returning to BioProcess International in 2019 as an official event partner, showcasing their continuous support for the industry.

Hear first hand from the GE Healthcare team, and meet with them face to face on September 9-12 at the Boston Convention and Exhibition Center.

About GE Healthcare

The Life Sciences business of GE Healthcare provides a wide range of bioprocessing products and services that enable the development and manufacture of high-quality biotherapeutics and vaccines.

Using their knowledge and expertise, they support their customers in increasing speed to market, while avoiding unnecessary costs and improving quality and performance in drug manufacturing.

As a provider of high-quality products, customized technical and commercial services, as well as design and construction of complete biomanufacturing solutions, GE Healthcare support the biopharmaceutical industry in working to make health visions a reality.

GE Healthcare Products

GE Healthcare offer an extensive range of products and services across the entire healthcare spectrum. The Life Sciences division offer products and applications divided by 8 core categories;

  • Bioprocessing
  • Cell and Gene Therapy
  • Cellular Analysis
  • Enterprise Solutions
  • Forensics
  • Genomics
  • Lab Filtration
  • Protein Research

You can explore a full range of GE Healthcare Life Sciences products and services on their website here.

GE Healthcare also supports

We're bringing you

  • Strategies and multi-factor approaches for bioreactor scale-up

  • Real-time control executed by in-line sensing

  • Scalability of a transfection-mediated GMP production platform for novel Clade F rAAV vectors